SAN DIEGO, Jan. 10, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: CRNX) today announced that on January 10, 2025, the Compensation ...

POTOMAC, MD / ACCESSWIRE / January 8, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") announced today that its ongoing Phase 2 trial for agitation in Alzheimer's disease ...

Case reports published in medical literature suggest that tafenoquine combined with standard-of-care treatment exhibits a ...

Fintel reports that on January 10, 2025, Maxim Group upgraded their outlook for Reviva Pharmaceuticals Holdings ...

Expected readouts in diabetes, cancer and depression headline a series of study results that could help the biotechnology ...

Fintel reports that on January 10, 2025, Roth MKM initiated coverage of Verona Pharma plc - Depositary Receipt () ...

In a report released today, Cory Jubinville, PhD from LifeSci Capital maintained a Buy rating on Crinetics Pharmaceuticals (CRNX – Research ...

DS Investment & Securities analyzed on the 10th that Hanmi Pharmaceutical will enter a structural recovery phase this year.

KARACHI: The Faculty of Pharmacy and Pharmaceutical Sciences of the University of Karachi and Dimension Research Clinical ...

- Positive interim results in infants and young children with ENPP1 Deficiency showed improvements from baseline in multiple measures of disease, including survival, heart function, and stabilization ...

About ADARx Pharmaceuticals ADARx Pharmaceuticals, Inc. is a late-stage clinical biotechnology company dedicated to transforming cutting-edge science into next-generation RNA medicines across a wide ...

The patent, when formally approved, will reinforce protection for Silo's lead asset, SPC-15, an intranasal treatment ...